Provided by Tiger Trade Technology Pte. Ltd.

Corbus Pharmaceuticals

10.38
+0.54005.49%
Post-market: 10.15-0.2300-2.22%19:30 EDT
Volume:604.02K
Turnover:6.15M
Market Cap:200.76M
PE:-1.70
High:10.42
Open:9.97
Low:9.90
Close:9.84
52wk High:20.56
52wk Low:7.12
Shares:19.34M
Float Shares:17.42M
Volume Ratio:1.33
T/O Rate:3.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.0889
EPS(LYR):-5.9000
ROE:-95.58%
ROA:-53.00%
PB:1.96
PE(LYR):-1.76

Loading ...

Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS), Corbus Pharmaceuticals (CRBP) and Artivion (AORT)

TIPRANKS
·
Apr 07

Corbus reports FDA alignment for CRB-701, CMO Dominic Smethurst departure

TIPRANKS
·
Apr 07

Corbus CMO Dominic Smethurst to step down June 30, 2026

Reuters
·
Apr 07

BRIEF-Corbus Pharmaceuticals Announces Broad Alignment With FDA On Registration Path For Crb-701 In Second-Line Hnscc And Cervical Cancer

Reuters
·
Apr 07

Corbus Pharmaceuticals Holdings Inc - to Continue FDA Interactions to Finalize Registration Study Protocols

THOMSON REUTERS
·
Apr 07

Corbus Pharmaceuticals price target raised to $40 from $39 at Mizuho

TIPRANKS
·
Apr 06

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Apr 03

Corbus Pharmaceuticals announces annual stockholders meeting notice

Reuters
·
Apr 03

Mizuho Securities Sticks to Their Buy Rating for Corbus Pharmaceuticals (CRBP)

TIPRANKS
·
Apr 02

Mizuho Lifts Price Target on Corbus Pharmaceuticals Holdings to $40 From $39, Keeps Outperform Rating

MT Newswires Live
·
Apr 02

Corbus Pharmaceuticals Holdings Inc. Stock Rises 6.3%, Outperforms Peers

Dow Jones
·
Apr 02

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
Mar 31

Corbus Pharmaceuticals Holdings Inc. Stock Slides 5.7%, Underperforms Peers

Dow Jones
·
Mar 28

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Mar 26

Corbus Pharmaceuticals Holdings Repeat Insider Selling Not A Positive Indicator

Simply Wall St.
·
Mar 24

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Mar 24

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Mar 20

Corbus Pharmaceuticals Holdings Inc. Stock Sheds 6.0%, Underperforms Peers

Dow Jones
·
Mar 19

Corbus CEO Yuval Cohen to join BMO Metabolic Health Summit panel

Reuters
·
Mar 18

Corbus Pharmaceuticals Holdings Inc. Stock Rises Monday, Still Underperforms Market

Dow Jones
·
Mar 17